Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy

Clinical trial NCT02088502 · UNKNOWN

Trial details

NCT number: NCT02088502
Sponsor: Isfahan University of Medical Sciences
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Contrast-Induced Nephropathy

Start date: 2013-09-01
Primary completion: 2014-04-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.